Report Brief: Countering the Problem of Falsified and Substandard Drugs
- Publisher:
- Institute of Medicine
- Publication Date:
- 13 February 2013
- Tags:
- Africa, Health and Medicine, Legal and Judicial Affairs
Falsified and substandard medicines provide little protection from disease and, worse, can expose consumers to major harm. Bad drugs pose potential threats around the world, but the nature of the risk varies by country, with higher risk in countries with minimal or non-existent regulatory oversight. While developed countries are not immune, the vast majority of problems occur in developing countries where underpowered and unsafe medicines affect millions. In West Africa, the value of falsified medicines rivals the billion dollar oil and cocaine trafficking industries, according to the United Nations Office of Drugs and Crime, which estimates that trafficking of fake malaria drugs alone exceeds $400 million.
AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.
Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.